Zinc induces depletion and aggregation of endogenous TDP-43

Free Radical Biology and Medicine

Volumn 48, Issue 9, 2010, Pages 1152-1161

  Caragounis, Aphrodite ^a   Price, Katherine Ann ^a   Soon, Cynthia P W ^a   Filiz, Gulay ^a   Masters, Colin L ^a   Li, Qiao Xin ^a   Crouch, Peter J ^a   White, Anthony R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amyotrophic lateral sclerosis; Free radicals; Frontotemporal lobar degeneration; Motor neuron disease; Neurotoxicity; Nuclear inclusions; Protein aggregation; TDP 43; Zinc

Indexed keywords

COPPER; HYDROGEN PEROXIDE; IRON; TAR DNA BINDING PROTEIN; ZINC;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CONTROLLED STUDY; CYTOSOL; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; NERVE CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CHLORIDES; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INCLUSION BODIES; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; RATS; ZINC COMPOUNDS;

MAMMALIA;

EID: 77950340946     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.01.035     Document Type: Article

References (35)

1. Banks G.T., Kuta A., Isaacs A.M., Fisher E.M TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander. Mamm. Genome 2008, 19:299-305.
2. Schymick J.C., Talbot K., Traynor B.J Genetics of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2007, 16(Spec. No. 2):R233-R242.
3. Cairns N.J., Neumann M., Bigio E.H., Holm I.E., Troost D., Hatanpaa K.J., Foong C., White C.L.R., Schneider J.A., Kretzschmar H.A., Carter D., Taylor-Reinwald L., Paulsmeyer K., Strider J., Gitcho M., Goate A.M., Morris J.C., Mishra M., Kwong L.K., Stieber A., Xu Y., Forman M.S., Trojanowski J.Q., Lee V.M., Mackenzie I.R TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 2007, 171:227-240.
4. Salazar A.M., Masters C.L., Gajdusek D.C., Gibbs C.J.J Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Ann. Neurol. 1983, 14:17-26.
5. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
6. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
7. Arai T., Mackenzie I.R., Hasegawa M., Nonoka T., Niizato K., Tsuchiya K., Iritani S., Onaya M., Akiyama H Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol. 2009, 117:125-136.
8. Kadokura A., Yamazaki T., Lemere C.A., Takatama M., Okamoto K Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Neuropathology 2009, 29:566-573.
9. Ayala Y.M., Pantano S., D'Ambrogio A., Buratti E., Brindisi A., Marchetti C., Romano M., Baralle F.E. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 2005, 348:575-588.
10. Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008, 283:13302-13309.
11. Nonaka T., Arai T., Buratti E., Baralle F.E., Akiyama H., Hasegawa M Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett. 2009, 583:394-400.
12. Nonaka T., Kametani F., Arai T., Akiyama H., Hasegawa M Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 2009, 18:3353-3364.
13. Barnham K.J., Haeffner F., Ciccotosto G.D., Curtain C.C., Tew D., Mavros C., Beyreuther K., Carrington D., Masters C.L., Cherny R.A., Cappai R., Bush A.I Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid. FASEB J. 2004, 18:1427-1429.
14. Martinez A., Carmona M., Portero-Otin M., Naudi A., Pamplona R., Ferrer I Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage. J. Neuropathol. Exp. Neurol. 2008, 67:1122-1136.
15. Molina-Holgado F., Hider R.C., Gaeta A., Williams R., Francis P Metals ions and neurodegeneration. Biometals 2007, 20:639-654.
16. Capasso M., Jeng J.M., Malavolta M., Mocchegiani E., Sensi S.L Zinc dyshomeostasis: a key modulator of neuronal injury. J. Alzheimer's Dis. 2005, 8:93-108. discussion 209-215.
17. Frazzini V., Rockabrand E., Mocchegiani E., Sensi S.L Oxidative stress and brain aging: is zinc the link?. Biogerontology 2006, 7:307-314.
18. Adlard P.A., Cherny R.A., Finkelstein D.I., Gautier E., Robb E., Cortes M., Volitakis I., Liu X., Smith J.P., Perez K., Laughton K., Li Q.X., Charman S.A., Nicolazzo J.A., Wilkins S., Deleva K., Lynch T., Kok G., Ritchie C.W., Tanzi R.E., Cappai R., Masters C.L., Barnham K.J., Bush A.I Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 2008, 59:43-55.
19. Crouch P.J., Hung L.W., Adlard P.A., Cortes M., Lal V., Filiz G., Perez K.A., Nurjono M., Caragounis A., Du T., Laughton K., Volitakis I., Bush A.I., Li Q.X., Masters C.L., Cappai R., Cherny R.A., Donnelly P.S., White A.R., Barnham K.J Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proc. Natl. Acad. Sci. USA 2009, 106:381-386.
20. Du T., Ciccotosto G.D., Cranston G.A., Kocak G., Masters C.L., Crouch P.J., Cappai R., White A.R Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation. Free Radic. Biol. Med. 2008, 44:44-55.
21. 2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290:L1028-1035.
22. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., Gass J., Rangachari V., Buratti E., Baralle F., Golde T.E., Dickson D.W., Petrucelli L Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 2009, 106:7607-7612.
23. Neumann M Molecular neuropathology of TDP-43 proteinopathies. Int. J. Mol. Sci. 2009, 10:232-246.
24. Gitcho M.A., Strider J., Carter D., Taylor-Reinwald L., Forman M.S., Goate A.M., Cairns N.J VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J. Biol. Chem. 2009, 284:12384-12398.
25. Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D TDP-43 is intrinsically aggregation-prone and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009, 284:20329-20339.
26. Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., Neumann M., Trojanowski J.Q., Lee V.M Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem. 2009, 284:8516-8524.
27. Sumi H., Kato S., Mochimaru Y., Fujimura H., Etoh M., Sakoda S Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2009, 68:37-47.
28. Maret W Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Signaling 2006, 8:1419-1441.
29. Kroncke K.D Cellular stress and intracellular zinc dyshomeostasis. Arch. Biochem. Biophys. 2007, 463:183-187.
30. Holtz M.L., Craddock S.D., Pettigrew L.C Rapid expression of neuronal and inducible nitric oxide synthases during post-ischemic reperfusion in rat brain. Brain Res. 2001, 898:49-60.
31. 2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiol. Biochem. J. 1999, 344(Pt 1):253-258.
32. Venturelli E., Villa C., Fenoglio C., Clerici F., Marcone A., Ghidoni R., Cortini F., Scalabrini D., Gallone S., Rainero I., Mandelli A., Restelli I., Binetti G., Cappa S., Mariani C., Giordana M.T., Bresolin N., Scarpini E., Galimberti D The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration. Eur. J. Neurol. 2009, 16:37-42.
33. Kim S.H., Shi Y., Hanson K.A., Williams L.M., Sakasai R., Bowler M.J., Tibbetts R.S Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. J. Biol. Chem. 2009, 284:8083-8092.
34. Bush A.I Drug development based on the metals hypothesis of Alzheimer's disease. J. Alzheimer's Dis. 2008, 15:223-240.
35. Crouch P.J., Harding S.M., White A.R., Camakaris J., Bush A.I., Masters C.L Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease. Int. J. Biochem. Cell Biol. 2008, 40:181-198.